VB
Vergent Bioscience, Inc.
SEC filingBiotechnology · Minneapolis, MN
Amount raised$18.7Msold at filing
Total offering$32M$13.3M still open
Investors in the raise20count reported to the SEC
FiledOct 20, 2025first sale Oct 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Bobby T. HelmedagDirector
Jeffrey T. YureckoExecutive Officer
Anita T. WatkinsDirector
John T. Santini, Jr.Executive Officer, Director
Raymond T. WongDirector
Douglas T. KohrsDirector
Executive officers, directors and promoters as listed on the Form D.